Search research articles
Contact Us
Filters
Showing results (221-230 of 455) with videos related to
Page
of 46
Sort By:
Nanotechnology
|
June 4, 2009
The fabrication and characterization of PbTiO3 nanomesas realized on nanostructured SrRuO3/SrTiO3 templates
C C You, R Takahashi, A Borg, et al.
Anticancer Research
|
July 1, 1987
Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age
H Olsson, B Lindahl, J Ranstam, et al.
British Journal of Haematology
|
August 24, 2006
High D-dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes
S Paneesha, E Cheyne, K French, et al.
Haematologica
|
February 9, 2006
High D-dimer level at presentation in patients with venous thrombosis is a marker for malignancy
S Paneesha, E Cheyne, K French, et al.
British Journal of Cancer
|
November 17, 2001
Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa
S Staff, J J Isola, O Johannsson, et al.
Annals of the Rheumatic Diseases
|
June 1, 1994
Increased IgA antibodies to cytokeratins in the spondyloarthropathies
A A Borg, N B Nixon, P T Dawes, et al.
Oncogene
|
January 1, 1991
ERBB2 amplification in breast cancer with a high rate of proliferation
A Borg, B Baldetorp, M Fernö, et al.
Endocrinology
|
May 1, 1992
Interleukin-1 beta increases the activity of superoxide dismutase in rat pancreatic islets
L A Borg, E Cagliero, S Sandler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1989
A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease
A Borg-Grech, J A Radford, D Crowther, et al.
Journal of Surgical Oncology
|
April 1, 1988
Prognostic significance of estrogen and progesterone receptors in stage II breast cancer
S Rydén, M Fernö, A Borg, et al.
Page
of 46
Search research articles
Search
Showing results (221-230 of 455) with videos related to
Sort By:
Page
of 46
Nanotechnology
|
June 4, 2009
The fabrication and characterization of PbTiO3 nanomesas realized on nanostructured SrRuO3/SrTiO3 templates
C C You, R Takahashi, A Borg, et al.
Anticancer Research
|
July 1, 1987
Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age
H Olsson, B Lindahl, J Ranstam, et al.
British Journal of Haematology
|
August 24, 2006
High D-dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes
S Paneesha, E Cheyne, K French, et al.
Haematologica
|
February 9, 2006
High D-dimer level at presentation in patients with venous thrombosis is a marker for malignancy
S Paneesha, E Cheyne, K French, et al.
British Journal of Cancer
|
November 17, 2001
Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa
S Staff, J J Isola, O Johannsson, et al.
Annals of the Rheumatic Diseases
|
June 1, 1994
Increased IgA antibodies to cytokeratins in the spondyloarthropathies
A A Borg, N B Nixon, P T Dawes, et al.
Oncogene
|
January 1, 1991
ERBB2 amplification in breast cancer with a high rate of proliferation
A Borg, B Baldetorp, M Fernö, et al.
Endocrinology
|
May 1, 1992
Interleukin-1 beta increases the activity of superoxide dismutase in rat pancreatic islets
L A Borg, E Cagliero, S Sandler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1989
A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease
A Borg-Grech, J A Radford, D Crowther, et al.
Journal of Surgical Oncology
|
April 1, 1988
Prognostic significance of estrogen and progesterone receptors in stage II breast cancer
S Rydén, M Fernö, A Borg, et al.
Page
of 46